1Schwaiger M, Bengel FM. From thallium scan to molecular imaging [J]. Mol Imaging Biol,2002,4(6) :387.
2Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) [ J]. Radiother Oncol,2002,62 ( 1 ) :51.
3Schmucking M, Baum RP, Griesinger F, et al. Molecular whole-body cancer staging using positron emission tomography : consequences for therapeutic management and metabolic radiation treatment planning[J]. Recent Result Cancer Res,2003,162 ( 2 ) : 195.
4Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT:the impact of 18FDG-hybrid PET fusion [J]. Int J Radiat Oncol Biol Phys,2001,51 (4) :923.
5Caldwell CB, Mah K, Skinner M, et al. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET [ J]. Int J Radiat Oncol Biol Phys,2003,55 (5) :1381.
6Nuutinen J, Sonninen P, Lehikoinen P, et al. Radiotherapy treatment planning and long-term follow-up with [ ( 11 ) C ] methionine PET in patients with low-grade astrocytoma [ J ]. Int J Radiat Oncol Biol Phys,2000,48 ( 1 ) :43.
7Grosu AL, Weber W, Feldmann H J, et al. First experience with 1-123- alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas [J]. Int J Radiat Oncol Biol Phys,2000,47(2) :517.
8Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18FDG- PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas [J]. Int J Radiat Oncol Biol Phys,2002,53 (4) :1051.
9Geets X, Daisne JF, Gregoire V, et al. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG- PET and CT [ J]. Radiother Oncol,2004,71 ( 3 ) :267.
10Scarfone C, Lavely WC, Cmelak A J, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging [J]. J Nucl Med,2004,45(4) :543.
